The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo

Oncogene
G MerdzhanovaB Eymin

Abstract

The transcription factor E2F1 has a crucial role in the control of cell growth and has been shown to regulate neoangiogenesis in a p53-dependent manner through inhibition of activity of the VEGF-A (vascular endothelial growth factor) promoter. Besides being regulated by transcription, VEGF-A is also highly regulated by pre-mRNA alternative splicing, resulting in the expression of several VEGF isoforms with either pro-(VEGF(xxx)) or anti-(VEGF(xxx)b) angiogenic properties. Recently, we identified the SR (Ser-Rich/Arg) protein SC35, a splicing factor, as a new transcriptional target of E2F1. Here, we show that E2F1 downregulates the activity of the VEGF-A promoter in tumour cells independently of p53, leading to a strong decrease in VEGF(xxx) mRNA levels. We further show that, strikingly, E2F1 alters the ratio of pro-VEGF(xxx) versus anti-VEGF(xxx)b angiogenic isoforms, favouring the antiangiogenic isoforms, by a mechanism involving the induction of SC35 expression. Finally, using lung tumour xenografts in nude mice, we provide evidence that E2F1 and SC35 proteins increase the VEGF(165)b/VEGF ratio and decrease tumour neovascularization in vivo. Overall, these findings highlight E2F1 and SC35 as two regulators of the VEGF(xxx)/VE...Continue Reading

Associated Clinical Trials

References

Sep 23, 2000·Nature·P Carmeliet, R K Jain
Jun 5, 2003·Nature Medicine·Napoleone FerraraJennifer LeCouter
Jun 4, 2004·The New England Journal of Medicine·Herbert HurwitzFairooz Kabbinavar
May 24, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Herbert I HurwitzFairooz Kabbinavar
Jul 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Gangjian QinDouglas W Losordo
Oct 10, 2006·Cancer Letters·Michael R LadomeryDavid O Bates
Feb 6, 2007·International Journal of Cancer. Journal International Du Cancer·Raul CatenaAlfonso Calvo
Mar 31, 2007·Nature Reviews. Drug Discovery·Judah Folkman
Jun 28, 2007·British Journal of Cancer·R O Pritchard-JonesD O Bates
Sep 23, 2008·Trends in Cell Biology·Shirley Polager, Doron Ginsberg
Mar 25, 2009·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Ana Paula Elias, Sergio Dias
Sep 29, 2009·Nature Structural & Molecular Biology·Giulia FontemaggiGiovanni Blandino

❮ Previous
Next ❯

Citations

Mar 26, 2013·Chromosoma·Zhihong Zhou, Xiang-Dong Fu
Mar 1, 2012·Human Molecular Genetics·Eugenio Fernandez AlanisFranco Pagani
Sep 10, 2013·Journal of Molecular Cell Biology·David EngelmannBrigitte M Pützer
Feb 9, 2012·Molecular and Cellular Biology·Manabu TauraHirofumi Kai
Jan 11, 2012·Reproduction : the Official Journal of the Society for the Study of Fertility·Y QiuD O Bates
Dec 5, 2014·Nature Medicine·Joshua M Boucher, Victoria L Bautch
Dec 18, 2013·Oncogene·S Oltean, D O Bates
Mar 8, 2016·Cytokine & Growth Factor Reviews·Mustafa Gokhan ErtosunOzes Osman Nidai
Sep 7, 2013·Journal of Ovarian Research·Sergio Juárez-MéndezJosé Moreno
Jul 24, 2012·Biochemical Society Transactions·Sebastian OlteanDavid O Bates
Dec 2, 2011·Journal of Nucleic Acids·Sophie GermannDidier Auboeuf
Jul 15, 2015·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Wei ShenJuncheng Dai
Aug 15, 2015·BioMed Research International·Maria Roméria da SilvaGustavo Costa Bressan
Feb 16, 2013·Transcription·Walbert J BakkerAlain de Bruin
Oct 19, 2012·Cell Adhesion & Migration·Maria Peiris-Pagès
Sep 10, 2014·Antioxidants & Redox Signaling·Sabrina FarrokhHeiner Schaal
Oct 4, 2016·Journal of Cellular and Molecular Medicine·Po-Yuan HsuSuh-Hang H Juo
Apr 26, 2018·International Journal of Molecular Sciences·Effrosyni Antonopoulou, Michael Ladomery
Jun 18, 2014·Molecular and Cellular Biology·Daniel P HollernEran R Andrechek
Sep 20, 2017·Oncogene·B G M W WeijtsA de Bruin
Dec 31, 2016·Pharmacological Reviews·David O BatesLucy F Donaldson
Apr 28, 2019·International Journal of Molecular Sciences·Elizabeth Bowler, Sebastian Oltean
Jul 17, 2012·Molecular Cancer Research : MCR·Orit FeldsteinDoron Ginsberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.